Rhythm Pharmaceuticals Stock Analysis

RYTM Stock  USD 89.20  1.48  1.63%   
Rhythm Pharmaceuticals is overvalued with Real Value of 68.59 and Hype Value of 89.2. The main objective of Rhythm Pharmaceuticals stock analysis is to determine its intrinsic value, which is an estimate of what Rhythm Pharmaceuticals is worth, separate from its market price. There are two main types of Rhythm Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The Rhythm Pharmaceuticals stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Rhythm Pharmaceuticals is usually not traded on Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day. Rhythm Stock trading window is adjusted to America/New York timezone.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rhythm Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
To learn how to invest in Rhythm Stock, please use our How to Invest in Rhythm Pharmaceuticals guide.

Rhythm Stock Analysis Notes

About 99.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 0.75. Rhythm Pharmaceuticals recorded a loss per share of 2.8. The entity had not issued any dividends in recent years. Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts. Rhythm Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 140 people. To find out more about Rhythm Pharmaceuticals contact the company at 857 264 4280 or learn more at https://rhythmtx.com.

Rhythm Pharmaceuticals Investment Alerts

Rhythm Pharmaceuticals is way too risky over 90 days horizon
Rhythm Pharmaceuticals appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 130.13 M. Net Loss for the year was (260.6 M) with profit before overhead, payroll, taxes, and interest of 122.65 M.
Rhythm Pharmaceuticals currently holds about 235.6 M in cash with (113.88 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.64.
Over 99.0% of the company shares are owned by institutional investors
Latest headline from thelincolnianonline.com: Gossamer Bio Now Covered by Analysts at Scotiabank

Rhythm Pharmaceuticals Upcoming and Recent Events

6th of March 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Rhythm Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 5.89 B.

Rhythm Profitablity

The company has Profit Margin (PM) of (1.23) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.44) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.44.

Technical Drivers

As of the 21st of July, Rhythm Pharmaceuticals holds the Risk Adjusted Performance of 0.1393, semi deviation of 2.1, and Coefficient Of Variation of 712.39. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Rhythm Pharmaceuticals, as well as the relationship between them. Please check Rhythm Pharmaceuticals market risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Rhythm Pharmaceuticals is priced some-what accurately, providing market reflects its current price of 89.2 per share. Given that Rhythm Pharmaceuticals has jensen alpha of 0.762, we recommend you to check out Rhythm Pharmaceuticals's recent market performance to make sure the company can sustain itself at a future point.

Rhythm Pharmaceuticals Price Movement Analysis

The output start index for this execution was eleven with a total number of output elements of fifty. The Simple Moving Average indicator is calculated by adding the closing price of Rhythm Pharmaceuticals for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Rhythm Pharmaceuticals short-term fluctuations and highlight longer-term trends or cycles.

Rhythm Pharmaceuticals Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Rhythm Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Rhythm Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Rhythm Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Alastair Garfield over two weeks ago
Acquisition by Alastair Garfield of 4445 shares of Rhythm Pharmaceuticals subject to Rule 16b-3
 
Alastair Garfield over two weeks ago
Acquisition by Alastair Garfield of 4445 shares of Rhythm Pharmaceuticals subject to Rule 16b-3
 
Mcgirr David W J over three weeks ago
Acquisition by Mcgirr David W J of 4712 shares of Rhythm Pharmaceuticals subject to Rule 16b-3
 
Tetrault Lynn A. over a month ago
Disposition of 4000 shares by Tetrault Lynn A. of Rhythm Pharmaceuticals subject to Rule 16b-3
 
Christopher German over a month ago
Disposition of 2069 shares by Christopher German of Rhythm Pharmaceuticals at 67.19 subject to Rule 16b-3
 
Meeker David P over a month ago
Disposition of 43620 shares by Meeker David P of Rhythm Pharmaceuticals at 4.59 subject to Rule 16b-3
 
Yann Mazabraud over two months ago
Disposition of 6745 shares by Yann Mazabraud of Rhythm Pharmaceuticals at 65.0773 subject to Rule 16b-3
 
Yann Mazabraud over three months ago
Disposition of 8905 shares by Yann Mazabraud of Rhythm Pharmaceuticals subject to Rule 16b-3
 
Yann Mazabraud over three months ago
Disposition of 10375 shares by Yann Mazabraud of Rhythm Pharmaceuticals subject to Rule 16b-3
 
Yann Mazabraud over three months ago
Disposition of 75000 shares by Yann Mazabraud of Rhythm Pharmaceuticals at 22.28 subject to Rule 16b-3
 
Pamela Cramer over three months ago
Disposition of 982 shares by Pamela Cramer of Rhythm Pharmaceuticals at 57.22 subject to Rule 16b-3
 
Pamela Cramer over three months ago
Disposition of 3300 shares by Pamela Cramer of Rhythm Pharmaceuticals subject to Rule 16b-3

Rhythm Pharmaceuticals Outstanding Bonds

Rhythm Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Rhythm Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Rhythm bonds can be classified according to their maturity, which is the date when Rhythm Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Rhythm Pharmaceuticals Predictive Daily Indicators

Rhythm Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Rhythm Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Rhythm Pharmaceuticals Forecast Models

Rhythm Pharmaceuticals' time-series forecasting models are one of many Rhythm Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Rhythm Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Rhythm Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Rhythm Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Rhythm shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Rhythm Pharmaceuticals. By using and applying Rhythm Stock analysis, traders can create a robust methodology for identifying Rhythm entry and exit points for their positions.
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts. Rhythm Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 140 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Rhythm Pharmaceuticals to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio Manager Now

   

Portfolio Manager

State of the art Portfolio Manager to monitor and improve performance of your invested capital
All  Next Launch Module
When determining whether Rhythm Pharmaceuticals is a strong investment it is important to analyze Rhythm Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Rhythm Pharmaceuticals' future performance. For an informed investment choice regarding Rhythm Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rhythm Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
To learn how to invest in Rhythm Stock, please use our How to Invest in Rhythm Pharmaceuticals guide.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rhythm Pharmaceuticals. If investors know Rhythm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rhythm Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Rhythm Pharmaceuticals is measured differently than its book value, which is the value of Rhythm that is recorded on the company's balance sheet. Investors also form their own opinion of Rhythm Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Rhythm Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rhythm Pharmaceuticals' market value can be influenced by many factors that don't directly affect Rhythm Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rhythm Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Rhythm Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rhythm Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.